glp 1 drugs and levothyroxine Glucagon-like peptide-1 receptor agonists risk for cardiovascular events in older adults treated with levothyroxine: a target trial emulation The Link Between GLP-1 Drugs
Description
Glucagon-like peptide-1 (GLP-1) receptor agonists like liraglutide and semaglutide are effective treatments for weight loss in adults with obesity and have several cardiovascular benefits

Other GLP-1 Pills in the Pipeline Although Wegovy is the first GLP-1 pill the FDA has approved for weight management, drug manufacturers are funding trials for additional oral GLP-1 medications

Some researchers reach a point where tirzepatide stops producing results even at maximum doses

In summary, a reduced incretin effect on insulin secretion is associated with both genetic and metabolic alterations

Tirzepatide for the treatment of adults with type 2 diabetes: an endocrine perspective

Digital health platforms were already set up to prescribe online, ship medications directly to patients, drive patient engagement, and operate outside of traditional insurance systems
